Antidepressant drug prescription and incidence of COVID-19 in mental health outpatients: a retrospective cohort study.
Oleg O GlebovChristopher MuellerRobert J StewartDag AarslandGayan PereraPublished in: BMC medicine (2023)
This preliminary study suggests that ADs, and SSRIs in particular, may be of benefit for preventing COVID-19 infection spread in the community. The key limitations of the study are its retrospective nature and the focus on a mental health patient cohort. A more definitive assessment of AD and SSRI preventative potential warrants prospective studies in the wider demographic.